Topic Hub
8 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 8 of 8 clinical reviews.
A comprehensive review of the emerging mechanisms behind secondary hypogonadism, covering kisspeptin-GnRH signaling, inflammation, metabolic crosstalk, and what new research means for diagnosis and treatment.
Read clinical reviewHow common is secondary hypogonadism worldwide? Current epidemiology, rising prevalence drivers, regional differences, and what clinical guidelines say about screening and diagnosis.
Read clinical reviewA clinical review of racial and ethnic disparities in secondary hypogonadism diagnosis, treatment access, and outcomes, with primary-source citations and actionable clinical guidance.
Read clinical reviewSecondary hypogonadism carries measurable economic costs through lost wages, healthcare utilization, and long-term comorbidities. This evidence-based review covers the financial burden on patients, payers, and society.
Read clinical reviewA decade-by-decade clinical history of secondary hypogonadism treatment, from early testosterone injections to GnRH pump therapy and modern telehealth TRT protocols, with primary-source citations throughout.
Read clinical reviewA clinical deep-dive into the most contested questions in secondary hypogonadism diagnosis and treatment, including threshold debates, fertility preservation, cardiovascular risk, and the opioid-hypogonadism link.
Read clinical reviewA clinical comparison of secondary hypogonadism in children and adults, covering causes, diagnosis, laboratory thresholds, and treatment protocols for each age group, with primary-source citations throughout.
Read clinical reviewA clinical deep-dive into rare and atypical presentations of secondary hypogonadism, including genetic causes, drug-induced forms, functional variants, and diagnostic pitfalls. Reviewed by board-certified physicians.
Read clinical review